A Closer Look At CMS' Drug Price Disclosure Proposal
On Oct. 15, 2018, the Centers for Medicare & Medicaid Services released a proposed rule regarding the disclosure of pricing information in direct-to-consumer television ads for prescription drugs and biologics reimbursable...To view the full article, register now.
Already a subscriber? Click here to view full article